Inhibikase Therapeutics Inc (IKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 17,842 | 13,776 | 12,768 | 10,832 | 14,598 |
| Operating Income | -17,842 | -13,776 | -12,768 | -10,832 | -14,598 |
| Other Income | 1,461 | 1,041 | 838 | 917 | 919 |
| Pre-tax Income | -16,381 | -12,735 | -11,930 | -9,916 | -13,679 |
| Net Income Continuous | -16,381 | -12,735 | -11,930 | -9,916 | -13,679 |
| Net Income | $-16,381 | $-12,735 | $-11,930 | $-9,916 | $-13,679 |
| EPS Basic Total Ops | -0.10 | -0.10 | -0.13 | -0.11 | -0.15 |
| EPS Basic Continuous Ops | -0.10 | -0.10 | -0.13 | -0.11 | -0.15 |
| EPS Diluted Total Ops | -0.10 | -0.10 | -0.13 | -0.11 | -0.15 |
| EPS Diluted Continuous Ops | -0.10 | -0.10 | -0.13 | -0.11 | -0.15 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.09 | -0.13 | -0.11 | -0.15 |
| EBITDA(a) | $-17,842 | $-13,776 | $-12,745 | $-10,808 | $-14,585 |